Pegvisomant in acromegaly: an update

BACKGROUND: In 2007, we published an opinion document to review the role of pegvisomant (PEG) in the treatment of acromegaly. Since then, new evidence emerged on the biochemical and clinical effects of PEG and on its long-term efficacy and safety. AIM: We here reviewed the emerging aspects of the us...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Endocrinol Invest
Main Authors: Giustina, A., Arnaldi, G., Bogazzi, F., Cannavò, S., Colao, A., De Marinis, L., De Menis, E., Degli Uberti, E., Giorgino, F., Grottoli, S., Lania, A. G., Maffei, P., Pivonello, R., Ghigo, E.
格式: Artigo
語言:Inglês
出版: Springer International Publishing 2017
主題:
Review
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5443862/
https://ncbi.nlm.nih.gov/pubmed/28176221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40618-017-0614-1
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍